These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5115671)

  • 1. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.
    Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL
    J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.
    Couch RB; Douglas RG; Fedson DS; Kasel JA
    J Infect Dis; 1971 Nov; 124(5):473-80. PubMed ID: 5000515
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals.
    Schulman JL; Kilbourne ED
    J Infect Dis; 1971 Nov; 124(5):463-72. PubMed ID: 5115670
    [No Abstract]   [Full Text] [Related]  

  • 4. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.
    Kilbourne ED; Schulman JL; Schild GC; Schloer G; Swanson J; Bucher D
    J Infect Dis; 1971 Nov; 124(5):449-62. PubMed ID: 5115669
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines.
    Mogabgab WJ; Leiderman E
    JAMA; 1970 Mar; 211(10):1672-6. PubMed ID: 4984268
    [No Abstract]   [Full Text] [Related]  

  • 6. Influenza vaccines purified by zonal ultracentrifugation.
    Filczak K; Semkow R; Wrzos H; Zakrzewski K; Zgorzelska K
    Acta Microbiol Pol A; 1973; 5(3):261-70. PubMed ID: 4769561
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.
    Edmondson WP; Rothenberg R; White PW; Gwaltney JM
    Am J Epidemiol; 1971 Jun; 93(6):480-6. PubMed ID: 5562720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killed subunit influenza vaccine in children.
    Phillips CF; Phillips CA; Hodgkin WE; Forsyth BR; Rubin BA; Geraghty ME
    Pediatrics; 1973 Sep; 52(3):416-9. PubMed ID: 4738294
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of influenza by vaccines administered intramuscularly and intradermally].
    Trivello R; Gasparini V; Moschen ME; Romano M; Farisano G; Manicardi GC
    Ann Sclavo; 1972; 14(6):705-15. PubMed ID: 4130435
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 13. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity.
    Ruben FL; Jackson GG
    J Infect Dis; 1972 Jun; 125(6):656-64. PubMed ID: 4556572
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization of ferrets against influenza: a comparison of killed ferret grown and egg grown virus.
    Sweet C; Stephen J; Smith H
    Br J Exp Pathol; 1974 Jun; 55(3):296-304. PubMed ID: 4422501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses.
    Sugiura A; Yanagawa H; Enomoto C; Ueda M; Tobita K
    J Infect Dis; 1970 Dec; 122(6):472-8. PubMed ID: 5496135
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a live, attenuated recombinant influenza vaccine in high school children.
    Schiff GM; Linnemann CC; shea L; Lange B; Rotte T
    Infect Immun; 1975 Apr; 11(4):754-7. PubMed ID: 1168170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination of children against influenza].
    Pressler K; Sattler HJ; Schöck V
    Z Kinderheilkd; 1975; 118(4):265-9. PubMed ID: 1130119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization.
    Foy HM; Cooney MK; McMahan R; Bor E; Grayston JT
    JAMA; 1971 Aug; 217(8):1067-71. PubMed ID: 5109428
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination against Hong Kong influenza in Britain, 1968-9. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Tyrrell DA; Buckland R; Rubenstein D; Sharpe DM
    J Hyg (Lond); 1970 Sep; 68(3):359-68. PubMed ID: 4917914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.